Session Description: The session will cover the recent updates on how single-cell genomics is unveiling the clonal heterogeneity of myeloid neoplasia and how this information can guide clinical decisions.
Session Objectives:
• Understand the technology and potential uses of single-cell sequencing.
• Understand current findings from single-cell sequencing in myeloid neoplasms and their implications for how myeloid neoplasms first arise, how they involve, and the potential implications for patient management.
